LGDA and our partners LGD Alliance Europe and the Lymphatic Malformations Institute share resources and efforts to rise funds for LM/CLA research. This research has a direct impact on the care of patients and our understanding of these diseases.
-
Now Open and accepting LOIs. Deadline is March 20, 2026.
Pilot awards are intended to test new hypotheses or technologies that have the potential to significantly advance our understanding and/or treatment of CCLA, GLA, GSD, or KLA.
-
This award is made possible by the LGDA, LGD Alliance Europe (UK), LGD Alliance Europe, and the LMI.
-
These grants received matching funds through the Orphan Disease Center. Current fundraising efforts support the Alfie Milne Young Investigator Award.
Other items you may like
New research explores how microRNAs may help create targeted treatments for lymphatic malformations, offering hope for therapies with fewer side effects than current medications.
New research into the genetics of lymphatic malformations offers hope for earlier diagnosis and more personalized treatments.
Learn how lab-grown lymphatic tissues from children’s biopsies help doctors find hidden mutations and choose personalized treatments for lymphatic and vascular anomalies.
